Christine E. Engeland

1.5k total citations
38 papers, 1.1k citations indexed

About

Christine E. Engeland is a scholar working on Genetics, Oncology and Epidemiology. According to data from OpenAlex, Christine E. Engeland has authored 38 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Genetics, 20 papers in Oncology and 12 papers in Epidemiology. Recurrent topics in Christine E. Engeland's work include Virus-based gene therapy research (34 papers), CAR-T cell therapy research (17 papers) and Virology and Viral Diseases (12 papers). Christine E. Engeland is often cited by papers focused on Virus-based gene therapy research (34 papers), CAR-T cell therapy research (17 papers) and Virology and Viral Diseases (12 papers). Christine E. Engeland collaborates with scholars based in Germany, Canada and United States. Christine E. Engeland's co-authors include Guy Ungerechts, Christof von Kalle, Dirk Jäger, Rūta Veinalde, Christian Grossardt, Sascha Bossow, John C. Bell, Dirk Jaeger, Dirk M. Nettelbeck and Gemma Pidelaserra-Martí and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of Virology and Clinical Cancer Research.

In The Last Decade

Christine E. Engeland

38 papers receiving 1.1k citations

Peers

Christine E. Engeland
Feorillo Galivo United States
Xinping Fu United States
Oliver Ebert Germany
Victoria Roulstone United Kingdom
Yvonne McGrath United Kingdom
Diana J.M. van den Wollenberg Netherlands
Andrew Bateman United Kingdom
Roshni Ravindranathan United States
Murielle Gantzer France
Rae Myers United States
Feorillo Galivo United States
Christine E. Engeland
Citations per year, relative to Christine E. Engeland Christine E. Engeland (= 1×) peers Feorillo Galivo

Countries citing papers authored by Christine E. Engeland

Since Specialization
Citations

This map shows the geographic impact of Christine E. Engeland's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christine E. Engeland with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christine E. Engeland more than expected).

Fields of papers citing papers by Christine E. Engeland

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christine E. Engeland. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christine E. Engeland. The network helps show where Christine E. Engeland may publish in the future.

Co-authorship network of co-authors of Christine E. Engeland

This figure shows the co-authorship network connecting the top 25 collaborators of Christine E. Engeland. A scholar is included among the top collaborators of Christine E. Engeland based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christine E. Engeland. Christine E. Engeland is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Doerner, Johannes, Hubert Zirngibl, Maximilian Ackermann, et al.. (2023). A vector-encoded bispecific killer engager to harness virus-activated NK cells as anti-tumor effectors. Cell Death and Disease. 14(2). 104–104. 5 indexed citations
2.
Veinalde, Rūta, Gemma Pidelaserra-Martí, Chin Leng Tan, et al.. (2023). Virotherapy combined with anti-PD-1 transiently reshapes the tumor immune environment and induces anti-tumor immunity in a preclinical PDAC model. Frontiers in Immunology. 13. 1096162–1096162. 5 indexed citations
3.
Engeland, Christine E.. (2022). Safety study supports clinical development of immunotherapeutic oncolytic measles vaccine. Molecular Therapy — Methods & Clinical Development. 27. 90–92. 2 indexed citations
4.
Russell, Stephen J., John C. Bell, Christine E. Engeland, & Grant McFadden. (2022). Advances in oncolytic virotherapy. SHILAP Revista de lepidopterología. 2(1). 33–33. 20 indexed citations
5.
Engeland, Christine E., et al.. (2022). NK Cell Effector Functions and Bystander Tumor Cell Killing in Immunovirotherapy. Methods in molecular biology. 2521. 233–248. 1 indexed citations
6.
Engeland, Christine E., et al.. (2022). Improving immunovirotherapies: the intersection of mathematical modelling and experiments. SHILAP Revista de lepidopterología. 6. 100011–100011. 8 indexed citations
7.
Leber, Mathias F., Sascha Bossow, Christine E. Engeland, et al.. (2021). MicroRNA-sensitive oncolytic measles virus for chemovirotherapy of pancreatic cancer. Molecular Therapy — Oncolytics. 21. 340–355. 14 indexed citations
8.
Engeland, Christine E., et al.. (2021). Oncolytic viruses encoding bispecific T cell engagers: a blueprint for emerging immunovirotherapies. Journal of Hematology & Oncology. 14(1). 63–63. 79 indexed citations
9.
Veinalde, Rūta, Gemma Pidelaserra-Martí, Lara M. Jeworowski, et al.. (2021). Oncolytic measles vaccines encoding PD-1 and PD-L1 checkpoint blocking antibodies to increase tumor-specific T cell memory. Molecular Therapy — Oncolytics. 24. 43–58. 13 indexed citations
10.
Leber, Mathias F., Christine E. Engeland, Sascha Bossow, et al.. (2020). Sequencing of serially passaged measles virus affirms its genomic stability and reveals a nonrandom distribution of consensus mutations. Journal of General Virology. 101(4). 399–409. 5 indexed citations
11.
Pidelaserra-Martí, Gemma & Christine E. Engeland. (2020). Mechanisms of measles virus oncolytic immunotherapy. Cytokine & Growth Factor Reviews. 56. 28–38. 33 indexed citations
12.
Frisch, Janina, Christine E. Engeland, Frederic B. Thalheimer, et al.. (2019). Tumor-Specific Delivery of Immune Checkpoint Inhibitors by Engineered AAV Vectors. Frontiers in Oncology. 9. 52–52. 40 indexed citations
13.
Engeland, Christine E. & John C. Bell. (2019). Introduction to Oncolytic Virotherapy. Methods in molecular biology. 2058. 1–6. 21 indexed citations
14.
Abate‐Daga, Daniel, et al.. (2019). Mathematical Modeling of Oncolytic Virotherapy. Methods in molecular biology. 2058. 307–320. 10 indexed citations
15.
Speck, Tobias, Rūta Veinalde, Dirk Jaeger, et al.. (2018). Targeted BiTE Expression by an Oncolytic Vector Augments Therapeutic Efficacy Against Solid Tumors. Clinical Cancer Research. 24(9). 2128–2137. 86 indexed citations
16.
Leber, Mathias F., Sascha Bossow, Christine E. Engeland, et al.. (2018). Enhanced Control of Oncolytic Measles Virus Using MicroRNA Target Sites. Molecular Therapy — Oncolytics. 9. 30–40. 25 indexed citations
17.
Ungerechts, Guy, Christine E. Engeland, Christian J. Buchholz, et al.. (2017). Virotherapy Research in Germany: From Engineering to Translation. Human Gene Therapy. 28(10). 800–819. 20 indexed citations
18.
19.
Engeland, Christine E., Christian Grossardt, Rūta Veinalde, et al.. (2014). CTLA-4 and PD-L1 Checkpoint Blockade Enhances Oncolytic Measles Virus Therapy. Molecular Therapy. 22(11). 1949–1959. 239 indexed citations
20.
Leber, Mathias F., Sascha Bossow, Christine E. Engeland, et al.. (2014). MicroRNA-mediated multi-tissue detargeting of oncolytic measles virus. Cancer Gene Therapy. 21(9). 373–380. 51 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Feorillo Galivo Breakdown of academic impact, for papers by Xinping Fu Breakdown of academic impact, for papers by Oliver Ebert Breakdown of academic impact, for papers by Victoria Roulstone Breakdown of academic impact, for papers by Yvonne McGrath Breakdown of academic impact, for papers by Diana J.M. van den Wollenberg Breakdown of academic impact, for papers by Andrew Bateman Breakdown of academic impact, for papers by Roshni Ravindranathan Breakdown of academic impact, for papers by Murielle Gantzer Breakdown of academic impact, for papers by Rae Myers
Rankless by CCL
2026